Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

Caroline has questioned why her mother was not diagnosed with lung cancer before her death, despite her declining health and ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Recent research sheds light on how changes in the chemical structure of a protein called Interleukin-6 affect lung cancer’s ...

The study advanced beyond a one-size-fits-all model by developing both a global XGBoost classifier and cancer-type-specific ...

Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response.  They are secreted by ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Breast cancer is the most common cancer in women and the second leading cause of cancer-related deaths after lung cancer.

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.